Enzon Pharmaceuticals, Inc. (NASDAQ:ENZN)

CAPS Rating: 3 out of 5

A biopharmaceutical company dedicated to the development and commercialization of therapeutics to treat patients with cancer and adjacent diseases.

Recs

0
Player Avatar Hotpicks101 (29.34) Submitted: 1/21/2011 6:11:35 PM : Outperform Start Price: $11.57 ENZN Score: -48.35

Klarman. Cheap.

Featured Broker Partners


Advertisement